These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3597287)

  • 81. The promise and the pitfalls of autism research: an introductory note for new autism researchers.
    Amaral DG
    Brain Res; 2011 Mar; 1380():3-9. PubMed ID: 21129367
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Autoimmunity in autism.
    Enstrom AM; Van de Water JA; Ashwood P
    Curr Opin Investig Drugs; 2009 May; 10(5):463-73. PubMed ID: 19431079
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms.
    Heuer L; Ashwood P; Schauer J; Goines P; Krakowiak P; Hertz-Picciotto I; Hansen R; Croen LA; Pessah IN; Van de Water J
    Autism Res; 2008 Oct; 1(5):275-83. PubMed ID: 19343198
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Altered gene expression and function of peripheral blood natural killer cells in children with autism.
    Enstrom AM; Lit L; Onore CE; Gregg JP; Hansen RL; Pessah IN; Hertz-Picciotto I; Van de Water JA; Sharp FR; Ashwood P
    Brain Behav Immun; 2009 Jan; 23(1):124-33. PubMed ID: 18762240
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders.
    Wills S; Cabanlit M; Bennett J; Ashwood P; Amaral DG; Van de Water J
    Brain Behav Immun; 2009 Jan; 23(1):64-74. PubMed ID: 18706993
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Immunologic and neurodevelopmental susceptibilities of autism.
    Pessah IN; Seegal RF; Lein PJ; LaSalle J; Yee BK; Van De Water J; Berman RF
    Neurotoxicology; 2008 May; 29(3):532-45. PubMed ID: 18394707
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism.
    Martin LA; Ashwood P; Braunschweig D; Cabanlit M; Van de Water J; Amaral DG
    Brain Behav Immun; 2008 Aug; 22(6):806-16. PubMed ID: 18262386
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Maternal infection and white matter toxicity.
    Harry GJ; Lawler C; Brunssen SH
    Neurotoxicology; 2006 Sep; 27(5):658-70. PubMed ID: 16787664
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Hyperserotoninemia and altered immunity in autism.
    Burgess NK; Sweeten TL; McMahon WM; Fujinami RS
    J Autism Dev Disord; 2006 Jul; 36(5):697-704. PubMed ID: 16614791
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Familial autoimmune thyroid disease as a risk factor for regression in children with Autism Spectrum Disorder: a CPEA Study.
    Molloy CA; Morrow AL; Meinzen-Derr J; Dawson G; Bernier R; Dunn M; Hyman SL; McMahon WM; Goudie-Nice J; Hepburn S; Minshew N; Rogers S; Sigman M; Spence MA; Tager-Flusberg H; Volkmar FR; Lord C
    J Autism Dev Disord; 2006 Apr; 36(3):317-24. PubMed ID: 16598435
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications.
    Sperner-Unterweger B
    Drugs; 2005; 65(11):1493-520. PubMed ID: 16033289
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease.
    Vojdani A; Bazargan M; Vojdani E; Samadi J; Nourian AA; Eghbalieh N; Cooper EL
    Clin Diagn Lab Immunol; 2004 May; 11(3):515-24. PubMed ID: 15138176
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Brief report: immune factors in autism: a critical review.
    Krause I; He XS; Gershwin ME; Shoenfeld Y
    J Autism Dev Disord; 2002 Aug; 32(4):337-45. PubMed ID: 12199139
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Immunological treatments for autism.
    Gupta S
    J Autism Dev Disord; 2000 Oct; 30(5):475-9. PubMed ID: 11098887
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Brief report: a pilot open clinical trial of intravenous immunoglobulin in childhood autism.
    DelGiudice-Asch G; Simon L; Schmeidler J; Cunningham-Rundles C; Hollander E
    J Autism Dev Disord; 1999 Apr; 29(2):157-60. PubMed ID: 10382136
    [No Abstract]   [Full Text] [Related]  

  • 96. Brief report: immunoglobulin A deficiency in a subset of autistic subjects.
    Warren RP; Odell JD; Warren WL; Burger RA; Maciulis A; Daniels WW; Torres AR
    J Autism Dev Disord; 1997 Apr; 27(2):187-92. PubMed ID: 9105969
    [No Abstract]   [Full Text] [Related]  

  • 97. Dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics.
    Gupta S; Aggarwal S; Heads C
    J Autism Dev Disord; 1996 Aug; 26(4):439-52. PubMed ID: 8863094
    [No Abstract]   [Full Text] [Related]  

  • 98. Lymphocyte subsets and interleukin-2 receptors in autistic children.
    Denney DR; Frei BW; Gaffney GR
    J Autism Dev Disord; 1996 Feb; 26(1):87-97. PubMed ID: 8819772
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Receptor inhibition by immunoglobulins: specific inhibition by autistic children, their relatives, and control subjects.
    Cook EH; Perry BD; Dawson G; Wainwright MS; Leventhal BL
    J Autism Dev Disord; 1993 Mar; 23(1):67-78. PubMed ID: 8463203
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Weaning time of children with infantile autism.
    Tanoue Y; Oda S
    J Autism Dev Disord; 1989 Sep; 19(3):425-34. PubMed ID: 2793787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.